Analysis of glycyrrhizin binding to protein HMGB1

Kang, 2014, HMGB1 in health and disease, Mol Aspects Med, 40, 1, 10.1016/j.mam.2014.05.001 Denning, 2019, DAMPs and NETs in Sepsis, Front Immunol, 10, 2536, 10.3389/fimmu.2019.02536 Yang, 2020, Targeting Inflammation Driven by HMGB1, Front Immunol, 11, 484, 10.3389/fimmu.2020.00484 Angelopoulou, 2020, Exploring the role of high-mobility group box 1 (HMGB1) protein in the pathogenesis of Huntington’s disease, J Mol Med (Berl), 98, 325, 10.1007/s00109-020-01885-z Paudel, 2020, Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting, Cells, 9, 10.3390/cells9020383 Tripathi, 2019, HMGB1 protein as a novel target for cancer, Toxicol Rep, 6, 253, 10.1016/j.toxrep.2019.03.002 Cheng, 2020, HMGB1: an overview of its versatile roles in the pathogenesis of colorectal cancer, Cell Oncol (Dordr), 43, 177, 10.1007/s13402-019-00477-5 VanPatten, 2018, High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target, J Med Chem, 61, 5093, 10.1021/acs.jmedchem.7b01136 Kim, 2018, Inflachromene inhibits autophagy through modulation of Beclin 1 activity, J Cell Sci, 131, 211201, 10.1242/jcs.211201 Lee, 2014, A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation, Nat Chem Biol, 10, 1055, 10.1038/nchembio.1669 Lee, 2019, A validated UPLC-MS/MS method for pharmacokinetic study of inflachromene, a novel microglia inhibitor, J Pharm Biomed Anal, 166, 183, 10.1016/j.jpba.2019.01.013 Vijayakumar, 2019, High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics, Curr Drug Targets, 20, 1474, 10.2174/1389450120666190618125100 Pastorino, 2018, Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review, Phytother Res, 32, 2323, 10.1002/ptr.6178 Hayashi, 2019, Field Survey of Glycyrrhiza Plants in Central Asia (5). Chemical Characterization of G bucharica Collected in Tajikistan, Chem Pharm Bull (Tokyo), 67, 534, 10.1248/cpb.c18-00881 Wang, 2020, A Comprehensive Review for Phytochemical, Pharmacological, and Biosynthesis Studies on Glycyrrhiza spp, Am J Chinese Med, 48, 17, 10.1142/S0192415X20500020 Shakeri, 2018, In depth chemical investigation of Glycyrrhiza triphylla Fisch roots guided by a preliminary HPLC-ESIMSn profiling, Food Chem, 248, 128, 10.1016/j.foodchem.2017.12.031 Li, 2019, Natural products in licorice for the therapy of liver diseases: Progress and future opportunities, Pharmacol Res, 144, 210, 10.1016/j.phrs.2019.04.025 Wang, 2018, Glycyrrhizin ameliorates atopic dermatitis-like symptoms through inhibition of HMGB1, Int Immunopharmacol, 6, 9, 10.1016/j.intimp.2018.04.029 Kowalska, 2019, 18β-Glycyrrhetinic acid: its core biological properties and dermatological applications, Int J Cosmet Sci, 41, 325, 10.1111/ics.12548 Cao, 2020, Glycyrrhizic acid as an adjunctive treatment for depression through anti-inflammation: A randomized placebo-controlled clinical trial, J Affect Disord, 265, 247, 10.1016/j.jad.2020.01.048 Petramfar, 2020, Efficacy of oral administration of licorice as an adjunct therapy on improving the symptoms of patients with Parkinson’s disease, A randomized double blinded clinical trial, J Ethnopharmacol, 247, 112226, 10.1016/j.jep.2019.112226 Kwon, 2020, A Review of the Pharmacological Efficacy and Safety of Licorice Root from Corroborative Clinical Trial Findings, J Med Food, 23, 12, 10.1089/jmf.2019.4459 Takahashi, 2019, Identification of glycyrrhizin metabolites in humans and of a potential biomarker of liquorice-induced pseudoaldosteronism: a multi-centre cross-sectional study, Arch Toxicol, 93, 3111, 10.1007/s00204-019-02588-2 Morinaga, 2018, Isolation of a novel glycyrrhizin metabolite as a causal candidate compound for pseudoaldosteronism, Sci Rep, 8, 15568, 10.1038/s41598-018-33834-9 Ishiuchi, 2019, 18β-glycyrrhetyl-3-O-sulfate would be a causative agent of licorice-induced pseudoaldosteronism, Sci Rep, 9, 1587, 10.1038/s41598-018-38182-2 Zou, 2018, Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin-induced model of liver injury, Int J Mol Med, 42, 2020 Cao, 2019, Protective Effects of Magnesium Glycyrrhizinate on Methotrexate-Induced Hepatotoxicity and Intestinal Toxicity May Be by Reducing COX-2, Front Pharmacol, 10, 119, 10.3389/fphar.2019.00119 Tan, 2018, Licorice root extract and magnesium isoglycyrrhizinate protect against triptolide-induced hepatotoxicity via up-regulation of the Nrf2 pathway, Drug Deliv, 25, 1213, 10.1080/10717544.2018.1472676 Weir, 1993, Structure of the HMG box motif in the B-domain of HMG1, EMBO J, 12, 1311, 10.1002/j.1460-2075.1993.tb05776.x Jorgensen, 2005, Molecular modeling of organic and biomolecular systems using BOSS and MCPRO, J Comput Chem, 26, 1689, 10.1002/jcc.20297 Vergoten, 2003, The SPASIBA force field as an essential tool for studying the structure and dynamics of saccharides, Biochimie, 85, 65, 10.1016/S0300-9084(03)00052-X Lagant, 2004, Increasing Normal Modes Analysis Accuracy: The SPASIBA Spectroscopic Force Field Introduced into the CHARMM Program, J Phys Chem A, 108, 4019, 10.1021/jp031178l Sánchez-Giraldo R, Acosta-Reyes FJ, Malarkey CS, Saperas N, Churchill ME, Campos JL. Two high-mobility group box domains act together to underwind and kink DNA. Acta Crystallogr D Biol Crystallogr. 71: 1423–1432. Dumitriu, 2015, Rovere-Querini P (2005) HMGB1: guiding immunity from within, Trends Immunol, 26, 381, 10.1016/j.it.2005.04.009 Knapp, 2004, The long acidic tail of high mobility group box 1 (HMGB1) protein forms an extended and flexible structure that interacts with specific residues within and between the HMG boxes, Biochemistry, 43, 11992, 10.1021/bi049364k Okuma, 2014, Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1-RAGE interaction, Neuropharmacology, 85, 18, 10.1016/j.neuropharm.2014.05.007 Sakamoto, 2001, Inhibitory effect of glycyrrhizin on the phosphorylation and DNA-binding abilities of high mobility group proteins 1 and 2 in vitro, Biol Pharm Bull, 24, 906, 10.1248/bpb.24.906 Cavone, 2011, 18β-glycyrrhetic acid inhibits immune activation triggered by HMGB1, a pro-inflammatory protein found in the tear fluid during conjunctivitis and blepharitis, Ocul Immunol Inflamm, 19, 180, 10.3109/09273948.2010.538121 Mollica, 2007, Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities, Chem Biol, 14, 431, 10.1016/j.chembiol.2007.03.007 Zandarashvili, 2013, Real-time kinetics of high-mobility group box 1 (HMGB1) oxidation in extracellular fluids studied by in situ protein NMR spectroscopy, J Biol Chem, 288, 11621, 10.1074/jbc.M113.449942 Yamaguchi, 2012, Structural insight into the ligand-receptor interaction between glycyrrhetinic acid (GA) and the high-mobility group protein B1 (HMGB1)-DNA complex, Bioinformation, 8, 1147, 10.6026/97320630081147 Moisy, 2012, HMGB1 protein binds to influenza virus nucleoprotein and promotes viral replication, J Virol, 86, 9122, 10.1128/JVI.00789-12 Hoppe, 2006, Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1, Exp Cell Res, 312, 3526, 10.1016/j.yexcr.2006.07.020 Du, 2013, Synthesis, biological evaluation, and molecular modeling of glycyrrhizin derivatives as potent high-mobility group box-1 inhibitors with anti-heart-failure activity in vivo, J Med Chem, 56, 97, 10.1021/jm301248y Zhang, 2017, Isoglycyrrhizinate Magnesium Enhances Hepatoprotective Effect of FK506 on Ischemia-Reperfusion Injury Through HMGB1 Inhibition in a Rat Model of Liver Transplantation, Transplantation, 101, 2862, 10.1097/TP.0000000000001941 Zhu, 2018, Berberine attenuates ischemia-reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation, Acta Pharmacol Sin, 39, 1706, 10.1038/s41401-018-0160-1 Galbiati, 2014, Role of ROS and HMGB1 in contact allergen-induced IL-18 production in human keratinocytes, J Invest Dermatol, 134, 2719, 10.1038/jid.2014.203 Yan, 2019, Protective effect of glycyrrhizic acid on cerebral ischemia/reperfusion injury via inhibiting HMGB1-mediated TLR4/NF-κB pathway, Biotechnol Appl Biochem, 66, 1024, 10.1002/bab.1825 Gui, 2020, Glycyrrhizin suppresses epithelial-mesenchymal transition by inhibiting high-mobility group box1 via the TGF-β1/Smad2/3 pathway in lung epithelial cells, Peer J, 8, 10.7717/peerj.8514 Tanaka, 2020, Restoration of calcium-induced differentiation potential and tight junction formation in HaCaT keratinocytes by functional attenuation of overexpressed high mobility group box-1 protein, Cytotechnology, 72, 165, 10.1007/s10616-019-00367-6 Sun, 2019, High-Mobility Group Box 1 Contributes to Cerebral Cortex Injury in a Neonatal Hypoxic-Ischemic Rat Model by Regulating the Phenotypic Polarization of Microglia, Front Cell Neurosci, 1, 506, 10.3389/fncel.2019.00506 Le, 2020, Cigarette smoke-induced HMGB1 translocation and release contribute to migration and NF-κB activation through inducing autophagy in lung macrophages, J Cell Mol Med, 24, 1319, 10.1111/jcmm.14789 Zheng, 2020, Glycyrrhizin mitigates radiation-induced acute lung injury by inhibiting the HMGB1/TLR4 signalling pathway, J Cell Mol Med, 24, 214, 10.1111/jcmm.14703 Liu, 2020, Glycyrrhizin protects IGFBP-3 knockout mice from retinal damage, Cytokine, 125, 154856, 10.1016/j.cyto.2019.154856 Wu, 2015, Protective Effects of Glycyrrhizic Acid and 18β-Glycyrrhetinic Acid against Cisplatin-Induced Nephrotoxicity in BALB/c Mice, J Agric Food Chem, 63, 1200, 10.1021/jf505471a Chen, 2017, Glycyrrhetinic acid suppressed hmgb1 release by up-regulation of Sirt6 in nasal inflammation, J Biol Regul Homeost Agents, 31, 269 Jiang, 2019, Glycyrrhetinic acid pretreatment attenuates liver ischemia/reperfusion injury via inhibiting TLR4 signaling cascade in mice, Int Immunopharmacol, 76, 105870, 10.1016/j.intimp.2019.105870 Shetty, 2011, 18α-glycyrrhetinic acid targets prostate cancer cells by down-regulating inflammation-related genes, Int J Oncol, 39, 635 Chintharlapalli, 2007, Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells, Mol Cancer Ther, 6, 1588, 10.1158/1535-7163.MCT-07-0022 Bordbar, 2014, Phenotypic and functional maturation of murine dendritic cells induced by 18 alpha- and beta-glycyrrhetinic acid, Immunopharmacol Immunotoxicol, 36, 52, 10.3109/08923973.2013.864670 Xu, 2013, Comparison of the exposure of glycyrrhizin and its metabolites and the pseudoaldosteronism after intravenous administration of alpha- and beta-glycyrrhizin in rat, Drug Res (Stuttg), 63, 620, 10.1055/s-0033-1349837 Yan, 2012, Effect of 18alpha-glycyrrhizic acid and 18beta-glycyrrhizic acid on P-gp function and expression in Caco-2 cells, Zhongguo Zhong Yao Za Zhi, 37, 99 Zou, 2009, Simultaneous determination of 18alpha- and 18beta-glycyrrhetic acid in human plasma by LC-ESI-MS and its application to pharmacokinetics, Biomed Chromatogr, 23, 54, 10.1002/bmc.1082 Yang, 2014, Synthesis, molecular docking and biological evaluation of glycyrrhizin analogs as anticancer agents targeting EGFR, Molecules, 19, 6368, 10.3390/molecules19056368 Wang, 2018, Design and preparation of derivatives of oleanolic and glycyrrhetinic acids with cytotoxic properties, Drug Des Devel Ther, 12, 1321, 10.2147/DDDT.S166051 Jin, 2018, Glycyrrhetinic acid derivatives containing aminophosphonate ester species as multidrug resistance reversers that block the NF-κB pathway and cell proliferation, Bioorg Med Chem Lett, 28, 3700, 10.1016/j.bmcl.2018.10.025 Jin, 2019, Mitochondria-targeted triphenylphosphonium conjugated glycyrrhetinic acid derivatives as potent anticancer drugs, Bioorg Chem, 85, 179, 10.1016/j.bioorg.2018.12.036 Shukla, 2020, 2D- and 3D-QSAR modelling, molecular docking and in vitro evaluation studies on 18β-glycyrrhetinic acid derivatives against triple-negative breast cancer cell line, J Biomol Struct Dyn, 38, 168, 10.1080/07391102.2019.1570868 Zheng, 2020, Design, Preparation and Studies Regarding Cytotoxic Properties of Glycyrrhetinic Acid Derivatives, Biol Pharm Bull, 43, 102, 10.1248/bpb.b19-00615 Mollica, 2008, The binding domain of the HMGB1 inhibitor carbenoxolone: theory and experiment, Chem Phys Lett, 456, 10.1016/j.cplett.2008.03.022 Mollica, 2011, HMGB1-carbenoxolone interactions: dynamics insights from combined nuclear magnetic resonance and molecular dynamics, Chem Asian J, 6, 1171, 10.1002/asia.201000726 Classen-Houben, 2009, Selective inhibition of 11beta-hydroxysteroid dehydrogenase 1 by 18alpha-glycyrrhetinic acid but not 18beta-glycyrrhetinic acid, J Steroid Biochem Mol Biol, 113, 248, 10.1016/j.jsbmb.2009.01.009 Yoshida, 2019, Selective and competitive inhibition of kynurenine aminotransferase 2 by glycyrrhizic acid and its analogues, Sci Rep, 9, 10243, 10.1038/s41598-019-46666-y Kamble, 2017, In silico Evidence for Binding of Pentacyclic Triterpenoids to Keap1-Nrf2 Protein-Protein Binding Site, Comb Chem High Throughput Screen, 20, 215, 10.2174/1386207319666161214111822 Yang, 2019, Glycyrrhetic acid monoglucuronide: sweetness concentration-response and molecular mechanism as a naturally high-potency sweetener, Food Sci Biotechnol, 28, 1187, 10.1007/s10068-019-00559-y Zhang, 2015, Structural basis for 18-β-glycyrrhetinic acid as a novel non-GSH analog glyoxalase I inhibitor, Acta Pharmacol Sin, 36, 1145, 10.1038/aps.2015.59 Wagle, 2018, Comparative study of selective in vitro and in silico BACE1 inhibitory potential of glycyrrhizin together with its metabolites, 18α- and 18β-glycyrrhetinic acid, isolated from Hizikia fusiformis, Arch Pharm Res, 41, 409, 10.1007/s12272-018-1018-2 Diao, 2013, Broad gap junction blocker carbenoxolone disrupts uterine preparation for embryo implantation in mice, Biol Reprod, 89, 31, 10.1095/biolreprod.113.110106